{"id":"https://openalex.org/W3202548245","doi":"https://doi.org/10.1016/j.annonc.2021.08.1734","title":"1791P A phase I pharmacology study of the dual MDMX/MDM2 inhibitor, ALRN 6924, in healthy volunteers","display_name":"1791P A phase I pharmacology study of the dual MDMX/MDM2 inhibitor, ALRN 6924, in healthy volunteers","publication_year":2021,"publication_date":"2021-09-01","ids":{"openalex":"https://openalex.org/W3202548245","doi":"https://doi.org/10.1016/j.annonc.2021.08.1734","mag":"3202548245"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2021.08.1734","doi":"https://doi.org/10.1016/j.annonc.2021.08.1734","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1734","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(21)03963-6/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.annalsofoncology.org/article/S0923-7534(21)03963-6/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078329903","display_name":"Christine Voors\u2010Pette","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119281","display_name":"QPS (Netherlands)","ror":"https://ror.org/02asacd21","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210119281","https://openalex.org/I4210146618"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"C. Voors-Pette","raw_affiliation_strings":["Clinical Research, QPS Netherlands, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, QPS Netherlands, Groningen, Netherlands","institution_ids":["https://openalex.org/I4210119281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038234281","display_name":"Wytze Aalders","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119281","display_name":"QPS (Netherlands)","ror":"https://ror.org/02asacd21","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210119281","https://openalex.org/I4210146618"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W. Aalders","raw_affiliation_strings":["Clinical Research, QPS Netherlands, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, QPS Netherlands, Groningen, Netherlands","institution_ids":["https://openalex.org/I4210119281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006248115","display_name":"Mari Brill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119281","display_name":"QPS (Netherlands)","ror":"https://ror.org/02asacd21","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210119281","https://openalex.org/I4210146618"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M. Brill","raw_affiliation_strings":["Clinical Research, QPS Netherlands, Groningen, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, QPS Netherlands, Groningen, Netherlands","institution_ids":["https://openalex.org/I4210119281"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087209198","display_name":"Daris Ferrari","orcid":"https://orcid.org/0000-0002-1941-7549","observed_orcids":["https://orcid.org/0000-0002-1941-7549"]},"institutions":[{"id":"https://openalex.org/I4210098625","display_name":"Aileron (United States)","ror":"https://ror.org/014w49905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098625"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Ferrari","raw_affiliation_strings":["Clinical Development, Aileron Therapeutics Inc, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Aileron Therapeutics Inc, Boston, MA, USA","institution_ids":["https://openalex.org/I4210098625"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030563807","display_name":"Allen Annis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098625","display_name":"Aileron (United States)","ror":"https://ror.org/014w49905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098625"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Annis","raw_affiliation_strings":["Clinical Development, Aileron Therapeutics Inc, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Aileron Therapeutics Inc, Boston, MA, USA","institution_ids":["https://openalex.org/I4210098625"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077804779","display_name":"Ulrich G. Steidl","orcid":"https://orcid.org/0000-0002-9458-1795","observed_orcids":["https://orcid.org/0000-0002-9458-1795"]},"institutions":[{"id":"https://openalex.org/I129975664","display_name":"Albert Einstein College of Medicine","ror":"https://ror.org/05cf8a891","country_code":"US","type":"education","lineage":["https://openalex.org/I129975664","https://openalex.org/I4210112371"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"U. Steidl","raw_affiliation_strings":["General, Albert Einstein College of Medicine, New York, NY, Bronx, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"General, Albert Einstein College of Medicine, New York, NY, Bronx, NY, USA","institution_ids":["https://openalex.org/I129975664"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018540281","display_name":"Manuel A. Aivado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098625","display_name":"Aileron (United States)","ror":"https://ror.org/014w49905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098625"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Aivado","raw_affiliation_strings":["Clinical Development, Aileron Therapeutics Inc, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Aileron Therapeutics Inc, Boston, MA, USA","institution_ids":["https://openalex.org/I4210098625"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110161340","display_name":"V. Vukovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098625","display_name":"Aileron (United States)","ror":"https://ror.org/014w49905","country_code":"US","type":"company","lineage":["https://openalex.org/I4210098625"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V. Vukovic","raw_affiliation_strings":["Clinical Development, Aileron Therapeutics Inc, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Aileron Therapeutics Inc, Boston, MA, USA","institution_ids":["https://openalex.org/I4210098625"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.1821,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.50773739,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"32","issue":null,"first_page":"S1222","last_page":"S1223"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p53-activation","display_name":"p53 activation","score":0.9419999718666077},{"id":"https://openalex.org/keywords/p53-inhibitors","display_name":"p53 inhibitors","score":0.6700000166893005},{"id":"https://openalex.org/keywords/alpha-helical-peptides","display_name":"alpha-helical peptides","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.6819999814033508},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.7129999995231628},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.5490000247955322},{"id":"https://openalex.org/keywords/pharmacology","display_name":"pharmacology","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2777221213","wikidata":"https://www.wikidata.org/wiki/Q10322346","display_name":"MDMX","level":4,"score":0.9563109874725342},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.763908863067627},{"id":"https://openalex.org/C2776192174","wikidata":"https://www.wikidata.org/wiki/Q18028978","display_name":"Mdm2","level":3,"score":0.643417477607727},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.5620232224464417},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5579438209533691},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4707496762275696},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.42158880829811096},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4165616035461426},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.3917197287082672},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3220304846763611},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19814160466194153},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.16794168949127197},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16695547103881836},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.15100711584091187},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12498825788497925}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2021.08.1734","doi":"https://doi.org/10.1016/j.annonc.2021.08.1734","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1734","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(21)03963-6/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2021.08.1734","doi":"https://doi.org/10.1016/j.annonc.2021.08.1734","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2021.08.1734","pdf_url":"https://www.annalsofoncology.org/article/S0923-7534(21)03963-6/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3202548245.pdf","grobid_xml":"https://content.openalex.org/works/W3202548245.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3203969607","https://openalex.org/W3095747953","https://openalex.org/W4307909241","https://openalex.org/W2666136463","https://openalex.org/W6995645853","https://openalex.org/W2904735514","https://openalex.org/W2993835348","https://openalex.org/W4235576882","https://openalex.org/W4249697152","https://openalex.org/W2955390241"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2021-10-11T00:00:00"}